HOSPIRA, INC. for HOSPIRA INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
S.1244 - FY14 FDA Appropriations bill relating to sequestered user fees.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JILL DOWELL | — |
| JULIANA REED | — |
Pharmacy PHA
H.R. 486 - relating to the compounding of drug products House Discussion Draft amending 503A of FFDCA with respect to pharmacy compounding S. 959 Compounding and Pedigree bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| JILL DOWELL | — |
| JULIANA REED | — |
Health Issues HCR
HR. 1919 - Safeguarding America's Pharmaceuticals Act of 2013. P.L. 111-148 - Patient Protection and Affordable Health Care Act provisions relating to biosimilar products. S. 957 and S. 959 - The Drug Supply Chain of Security Act. Issues relating to generic drug labeling.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JILL DOWELL | — |
| JULIANA REED | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.